VIMIAN.ST Stock: Vimian Group AB (publ) Stock Price, Analysis & Insights
Get live VIMIAN.ST stock price $30.00, comprehensive Vimian Group AB (publ) stock analysis, charts, news, and expert forecast. Real-time VIMIAN.ST stock data and investment insights.
Loading chart data...
Vimian Group AB (publ) (VIMIAN.ST) Overview
Vimian Group AB (publ) (VIMIAN.ST) is a publicly traded company in the Healthcare sector , specifically within the Medical - Diagnostics & Research industry . As of the latest trading session, VIMIAN.ST trades at $30.00 with a market capitalization of 15.78B . Over the past 52 weeks, VIMIAN.ST has traded between $24.18 and $43.58 , with the current price positioned at approximately 30% of this ...
Key Takeaways
- Operates in the Healthcare sector (Medical - Diagnostics & Research)
- Market cap: 15.78B
- Current price: $30.00
- 52-week range: $24.18 - $43.58
- P/E ratio: 39.47
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Vimian Group AB (publ) operates as a global enterprise in the animal health sector, segmenting its business into Specialty Pharma, MedTech, Diagnostics, and Veterinary Services. Through its Nextmune brand, the company delivers a comprehensive portfol...
Company Information
- CEO
- Alireza Tajbakhsh
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 1200
Contact Information
- Website
- https://vimian.com
- Address
- Riddargatan 19
- Country
- SE
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 39.5)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Vimian Group AB (publ) shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Vimian Group AB (publ)
- ⚠Investors should consider how Vimian Group AB (publ) fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 39.5) requires strong growth to justify
Market Cap
15.78B
P/E Ratio (TTM)
39.47
Beta
1.17
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare VIMIAN.ST with peer companies:
- Price
- $160.80+2.36% (1D)
- Market cap
- 18.86B
- Price
- $140.00+0.07% (1D)
- Market cap
- 11.25B
- Price
- $24.40+1.33% (1D)
- Market cap
- 6.65B
- Price
- $117.30+1.47% (1D)
- Market cap
- 16.94B
- Price
- $124.50+0.24% (1D)
- Market cap
- 12.26B
- Price
- $227.40+0.53% (1D)
- Market cap
- 14.98B
- Price
- $52.40+0.67% (1D)
- Market cap
- 19.24B
- Price
- $220.20+3.19% (1D)
- Market cap
- 7.55B
- Price
- $57.20-0.17% (1D)
- Market cap
- 8.11B
- Price
- $95.75-0.47% (1D)
- Market cap
- 12.97B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
43/100 ⭐⭐⭐
- Overall
- -1.0%
- NYSE
- -1.6%
- NASDAQ
- -0.4%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +0.3% | +1.3% | +1.9% | 19.8 | 83/100⭐⭐⭐⭐⭐ |
| Technology | +0.8% | +1.1% | +3.0% | 52.0 | 76/100⭐⭐⭐⭐⭐ |
| Basic Materials | +0.8% | +0.3% | +1.9% | 27.9 | 69/100⭐⭐⭐⭐ |
| Industrials | -0.3% | -0.9% | +2.7% | 43.0 | 64/100⭐⭐⭐⭐ |
| Communication Services | -0.8% | -1.3% | +0.4% | 21.9 | 48/100⭐⭐⭐ |
| Consumer Defensive | +0.6% | +1.6% | -2.5% | 31.2 | 44/100⭐⭐⭐ |
| Healthcare | -1.0% | -2.0% | +1.5% | 30.5 | 43/100⭐⭐⭐ |
| Real Estate | +0.5% | -1.1% | -0.0% | 50.0 | 33/100⭐⭐ |
| Energy | +0.5% | -3.6% | -0.0% | 35.9 | 31/100⭐⭐ |
| Utilities | +2.0% | -1.3% | -5.1% | 26.1 | 31/100⭐⭐ |
| Consumer Cyclical | -0.3% | +0.3% | -0.2% | 55.8 | 28/100⭐⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-06-13.